ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

Cancer Meetings Listed

November 1, 1996

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012